• Opinion
• [Reporter's View] Patent expired original
• by Lee, Tak-Sun May 3, 2023 05:38am

• Company
• Will Verzenio succeed in expanding benefits
• by Eo, Yun-Ho May 3, 2023 05:38am

• Policy
• The expansion of MPOX vaccination
• by Lee, Jeong-Hwan May 3, 2023 05:38am

• Company
• Boryung fails 3 of 5 patent challenges
• by Kim, Jin-Gu May 3, 2023 05:38am

• Company
• ‘Korea’s low reimb of orphan drugs needs to be improved’
• by Eo, Yun-Ho May 3, 2023 05:38am

• Policy
• Pemazyre received domestic product approval
• by Lee, Hye-Kyung May 2, 2023 03:40pm

• Company
• Boryung signed a contract to establish a joint venture with
• by Kim, Jin-Gu May 2, 2023 05:36am

• Company
• Eylea Prefilled Syringe can be prescribed at GHs in KOR
• by Eo, Yun-Ho May 2, 2023 05:36am

• Company
• Exkivity, an exon 20-targeted anti-cancer drug, can be presc
• by Eo, Yun-Ho May 2, 2023 05:35am

• Company
• Gilead’s HCV drug occupies 19% of HCV market in 5 mths
• by Kim, Jin-Gu May 2, 2023 05:35am